Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist

Published:2012-04-25 Issue:21 Volume:109 Page:E1369-E1376
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Iwaisako K.,Haimerl M.,Paik Y.-H.,Taura K.,Kodama Y.,Sirlin C.,Yu E.,Yu R. T.,Downes M.,Evans R. M.,Brenner D. A.,Schnabl B.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference25 articles.

1. What is the potential role of antifibrotic agents for the treatment of liver disease?

2. PPAR : a dagger in the heart of the metabolic syndrome

3. PPAR regulates glucose metabolism and insulin sensitivity

4. A selective peroxisome proliferator-activated receptor agonist promotes reverse cholesterol transport

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells;Biomedicine & Pharmacotherapy;2024-10

2. PPARβ/δ as a promising molecular drug target for liver diseases: A focused review;Clinics and Research in Hepatology and Gastroenterology;2024-06

3. Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis;European Journal of Medicinal Chemistry;2024-04

4. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis;New England Journal of Medicine;2024-02-29

5. Seladelpar combined with complementary therapies improves fibrosis, inflammation, and liver injury in a mouse model of nonalcoholic steatohepatitis;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3